Ośrodek Badań Klinicznych LabMed Agnieszka Karczmarczyk, Filip Karczmarczyk s.c.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The research at Ośrodek Badań Klinicznych LabMed Agnieszka Karczmarczyk, Filip Karczmarczyk s.c. focuses on cardiovascular diseases, with studies centered on atherosclerotic cardiovascular disease, heart failure, hyperlipidemia, and related high-risk conditions. These trials are designed to evaluate new treatment options and better understand how to reduce serious heart and blood vessel complications.
- Studies in atherosclerotic cardiovascular disease and obesity are assessing whether new therapies can lower the risk of major heart, stroke, and vascular events.
- Trials in heart failure are exploring treatment approaches for people with reduced ejection fraction, preserved or mildly reduced ejection fraction, and added risks such as obesity or kidney impairment.
- Research involving chronic kidney disease and hypertension is examining whether combined therapies can improve both kidney and cardiovascular outcomes.
- Lipid-focused studies are testing ways to improve control of LDL cholesterol and help prevent future cardiovascular events.
Overall, this site is contributing to clinical research aimed at improving prevention, treatment effectiveness, and long-term outcomes in people with cardiovascular disease and overlapping metabolic or kidney-related conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB5active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB6trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ośrodek Badań Klinicznych LabMed Agnieszka Karczmarczyk, Filip Karczmarczyk s.c.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV) | Amgen Inc. | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 4 | Unknown | 2024-07-12 | 2025-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.